edelfosine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Botzler, C | 1 |
Ellwart, J | 1 |
Günther, W | 1 |
Eissner, G | 1 |
Multhoff, G | 1 |
Verdonck, LF | 1 |
Witteveen, EO | 1 |
van Heugten, HG | 1 |
Rozemuller, E | 1 |
Rijksen, G | 1 |
2 other studies available for edelfosine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
Synergistic effects of heat and ET-18-OCH3 on membrane expression of hsp70 and lysis of leukemic K562 cells.
Topics: Adult; Antineoplastic Agents; Blood Cells; Bone Marrow Cells; Bone Marrow Purging; Cell Membrane; Co | 1999 |
Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
Topics: Adolescent; Adult; Aged; Blast Crisis; Bone Marrow; Bone Marrow Transplantation; Child; Colony-Formi | 1990 |